What one share of Revvity holds
We are a leading provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
Revvity’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-05; the balance sheet is as of 2026-07-05.
| Sales | $25.79 |
|---|---|
| Profit | $2.10 |
| Capex (buildings and equipment) | $0.62 |
| Free cash flow | $4.94 |
| Dividends | $0.28 |
| Cash and investments | $9.17 |
| Debt | $28.88 |
| Book value | $64.78 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2008 | $14.05 | $1.07 | $0.30 | $1.55 | — | $13.28 |
| 2009 | $13.30 | $0.70 | $0.22 | $1.06 | — | $13.92 |
| 2010 | $14.45 | $3.31 | $0.29 | $1.11 | $0.28 | $16.64 |
| 2011 | $16.85 | $0.07 | $0.27 | $1.71 | $0.28 | $16.28 |
| 2012 | $18.42 | $0.61 | $0.37 | $0.96 | $0.28 | $16.86 |
| 2013 | $19.01 | $1.47 | $0.34 | $1.05 | $0.28 | $17.71 |
| 2014 | $19.67 | $1.39 | $0.24 | $2.24 | $0.28 | $18.16 |
| 2015 | $18.57 | $1.87 | $0.25 | $2.28 | $0.28 | $18.76 |
| 2016 | $19.18 | $2.12 | $0.29 | $2.89 | $0.28 | $19.65 |
| 2017 | $20.36 | $2.64 | $0.35 | $2.25 | $0.28 | $22.68 |
| 2018 | $24.91 | $2.13 | $0.84 | $1.95 | $0.28 | $23.42 |
| 2019 | $25.86 | $2.04 | $0.68 | $2.58 | $0.28 | $25.32 |
| 2020 | $33.75 | $6.49 | $0.57 | $7.39 | $0.28 | $33.33 |
| 2021 | $32.81 | $8.08 | $0.74 | $11.35 | — | $56.57 |
| 2022 | $26.20 | $4.50 | $0.68 | $4.70 | $0.28 | $58.46 |
| 2023 | $22.04 | $5.55 | $0.65 | $0.08 | $0.28 | $63.79 |
| 2024 | $22.43 | $2.20 | $0.71 | $4.41 | $0.28 | $63.55 |
| 2025 | $24.50 | $2.07 | $0.63 | $4.37 | $0.28 | $64.57 |
Common questions about Revvity
How much does one share of Revvity earn?
Over the last 12 months, each share of Revvity earned $2.10 of profit on $25.79 of sales, keeping about 8¢ of every $1 (profit margin).
Does Revvity pay a dividend?
Yes. Revvity paid $0.28 per share in dividends over the last 12 months. That’s about 13¢ of each $1 of profit (payout ratio).
What is Revvity’s book value per share?
Revvity’s book value is $64.78 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of July 5, 2026.
How much cash and debt does each share of Revvity have?
Each share of Revvity has $9.17 of cash and investments and $28.88 of debt, as of July 5, 2026.
What is Revvity’s free cash flow per share?
$4.94 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Revvity’s profit per share changed over time?
Profit per share went from $1.07 in 2008 to $2.07 in 2025, growing about 4.0% a year (adjusted for stock splits).
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.